Llorens Pharmaceuticals Recalls Vitamin B-Complex Supplement
Areazine synthesizes this FDA recall directly from FDA's official public data feed. See our methodology for full source attribution and refresh cadence.
Llorens Pharmaceuticals International Division, Inc. is recalling Vitamin B-Complex, Vitamin C & Folic Acid Dietary Supplement due to foreign black particulate matter.
What this FDA recall tells you, and what most readers miss
This notice was issued by FDA on June 10, 2026 and geographically references United States. Its severity classification of "medium" signals how the issuing agency weighs the risk of harm if no action is taken - "critical" and "high" tier alerts typically carry direct consumer actions, while "medium" and "low" tend toward informational guidance or monitoring advisories. The category it belongs to - FDA Recalls - determines the consumer-protection framework behind it, which shapes what remedies (refunds, replacements, repairs, or the recall itself) are available to affected consumers and which agency holds statutory responsibility for enforcement.
Most readers skim a notice like this, check whether they are personally affected, and move on. The more useful lens is to verify its scope, source, and timestamp, then compare related notices without assuming that one record proves a broader trend.
Areazine pairs this record with the original agency URL so you can check the primary source before acting. Its related labels are recall, product-safety, fda, supplement.
What Happened
Llorens Pharmaceuticals International Division, Inc. has initiated a voluntary recall of a dietary supplement due to the presence of foreign black particulate matter.
Which Products Are Affected
The recall involves Vitamin B-Complex, Vitamin C & Folic Acid Dietary Supplement, Net Wt. 8 FL Oz (237mL) Amber PET modern round 24-400 bottle, 47 SERVING PER BOTTLE, packaged as 24 bottles per package. A total of 4,196 units are affected. The product was manufactured by Llorens Pharmaceutical in Miami, FL, with Lot: B2025 and Expiration Date: 08/27. It was distributed to MO, IL, NJ, NY, TX, FL, PR, MA, OK, VA, MN, IA, OH, GA, WI, WA, CA, IN, NC, CO, TN, WV, AZ, and DE.
What You Should Do
Consumers should not use the affected product. Contact information for returns or refunds has not been specified in the recall notice.
Why This Matters
The Class II recall addresses a foreign object hazard in a dietary supplement distributed across multiple states.
Source
FDA recall number H-0809-2026. https://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts
Original source: FDA Official Notice ↗
Related FDA Recalls
All FDA Recalls →Nationwide notices with similar length or severity timing 8
Two Areazine-derived peer sets for this FDA recall: nearest notices by body length and by same severity near the same agency date. Peers come from other categories so they are not the same-feed Related list above.
Similar body length
Nearest notices by article body length (1,093 characters here).
Similar severity timing
Same severity (medium) notices issued closest in time to June 10, 2026.
Frequently Asked Questions
Common questions about this FDA recall.